Tradestie Institutional Equity Comparison Engine

PACS vs BTSG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PACS Overall Edge

PACS Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to PACS Group, Inc. (PACS) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, PACS trades at 15.3x Forward P/E with 7.4% operating margin (+11.5% YoY revenue) versus BTSG at 25.9x Forward P/E and 3.5% operating margin (+26.4% YoY). In options structure, PACS sits in CONSOLIDATION (11th %ile IV; Dealer Gamma Walls on Pro) against BTSG sits in CONSOLIDATION (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner PACS
PACS 15.3x vs BTSG 25.9x Fwd P/E
Growth & Margin Winner PACS
Op Margin 7.4% vs 3.5% ยท YoY +11.5% vs +26.4%
Momentum & Technical Winner PACS
1Y +159.5% vs +94.8% ยท 52W Pos 79% vs 74%
Options & Structure Winner PACS
CONSOLIDATION (11th %ile IV) vs CONSOLIDATION (100th %ile IV)
PACS NYSE
PACS Group, Inc.
Services-Skilled Nursing Care Facilities
$43.67
+1.49% 1D
Market Cap $6.8B
1M Return -8.06%
1Y Return +159.48%
Forward P/E 15.3x
Unified AI Score
46.8 / 100 HOLD
Tech 35.0 Fund 48.0 Flow 62.0 Mom 50.0
BTSG NASDAQ
BrightSpring Health Services, Inc. Common Stock
Services-Home Health Care Services
$62.84
-1.84% 1D
Market Cap $12.7B
1M Return +3.25%
1Y Return +94.79%
Forward P/E 25.9x
Unified AI Score
42.6 / 100 HOLD
Tech 20.0 Fund 40.0 Flow 57.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: PACS +159.48% BTSG +94.79% Spread: +64.69 pp (PACS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period PACS Revenue BTSG Revenue PACS Op. Margin BTSG Op. Margin Margin Edge
FY2022 $2.40B $7.72B 9.6% 2.4% PACS
FY2023 $3.11B $7.69B 6.7% 0.8% PACS
FY2024 $4.09B $10.1B 3.0% 1.1% PACS
FY2025 $5.29B $12.9B 5.9% 2.3% PACS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: PACS (8) vs BTSG (2)
Institutional Metric PACS BTSG Criterion Row Winner
Market Capitalization Scale $6.8B $12.7B Larger Scale BTSG
Trailing P/E Ratio Valuation 26.2x 45.4x Lower Multiple PACS
Forward P/E Ratio Valuation 15.3x 25.9x Lower Multiple PACS
Revenue Growth (YoY) Growth +11.5% +26.4% Higher Growth BTSG
Operating Margin (TTM) Profitability 7.4% 3.5% Higher Margin PACS
Net Profit Margin Profitability 4.9% 2.7% Higher Margin PACS
Return on Equity (ROE) Capital Efficiency 26.5% 15.5% Higher ROE PACS
52-Week Range Position Momentum 79% ($14โ€“$52) 74% ($31โ€“$74) Stronger Trend PACS
Beta / 30D Volatility Risk Regime 0.78ฮฒ ยท 51% Vol 0.94ฮฒ ยท 59% Vol Lower Realized Risk PACS
Unified Institutional Score Composite Signal 46.8 / 100 (HOLD) 42.6 / 100 (HOLD) Higher Composite PACS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full PACS vs BTSG Buy Guide
PACS CONSOLIDATION
83d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 11th %ile
IV Regime Compressed (<25th %ile)
Live PACS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BTSG CONSOLIDATION
104d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live BTSG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither PACS nor BTSG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.